The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
And you look like another destructive bully trader looking for an entry point for quick self gain sitting itchy and wobbly on the sidelines offering ummmm? Nothing.
Perhaps numerous connectable models.
Just Covid for example
Model 1. Basic yes/no Frontline testing
Model 2. Testing and virus measurement
Model 3. Testing, virus measurement, sepsis monitor and treatment identification.
Model 4. Sepsis identification for front line
Model 5 sepsis monitor and treatment identification
The link!!
Sepsis is a life-threatening immune response to infection that leads to organ dysfunction, which is what happens in seriously ill COVID-19 patients, expert says.
We are creating a possible all in one! identifying Covid and required type treatment for severe cases.
9. Summary and outlook
The success of the near-infrared spectroscopy and nanotechnology-enabled Raman spectroscopy in investigating viruses like HIV and influenza ENSURES the potential of these techniques for studying SARS-CoV-2 with HIGH SPECIFICITY. With the development of superhydrophobic, slippery, and externally controllable SERS substrates, the rapid detection of coronavirus even at low concentration is possible.
The use of labeling strategies (bDNA-FISH) and click chemistry labeling of nucleic acids, lipids, and proteins PROVIDE HIGH SENSITIVITY in the fluorescence microscopic imaging-based viral studies.
With the advancement in technology and miniaturization, photonics-based biosensing platforms will become popular in terms of portability, cost involved, affordability, user-friendliness, and ready-to-use mode. As depicted in this progress, such photonics-based technologies offer a great promise for the rapid detection of deadly dangerous viruses like SARS-CoV-2.
https://www.sciencedirect.com/science/article/pii/S0956566321000403?via%3Dihub
New blood test, the competition takes 10 business days - $1250 a pop.
Detecting Alzheimer’s Gets Easier with a Simple Blood Test
New assays could reduce the need for costlier, more invasive brain scans and spinal fluid measures.
By Esther Landhuis on February 4, 2021
“The development of a blood-based test for Alzheimer’s disease is just phenomenal,” says Michelle Mielke, a neuroscientist and epidemiologist at the Mayo Clinic. “The field has been thinking about this for a very long time. It’s really been in the last couple of years that the possibility has come to fruition.”
PrecivityAD is the first blood test for Alzheimer’s to be cleared for widespread use and one of a new generation of such assays that could enable early detection of the leading neurodegenerative disease—perhaps decades before the onset of the first symptoms.
PrecivityAD is meant for 60- to 91-year-olds with early signs of cognitive impairment. The prescribing physician ships patient blood samples for analysis at C2N’s lab and receives results within 10 business days.
https://www.scientificamerican.com/article/detecting-alzheimers-gets-easier-with-a-simple-blood-test/
(Published 16 September 2020)
Operation Moonshot: Testing plan relies on technology that does not exist
Delivering mass testing on the scale and level of ambition set by the UK prime minister, Boris Johnson, will probably require “testing technology that currently does not exist,” say leaked documents revealed by The BMJ.1
The Operation Moonshot plans, which could see the government spend over £100bn to ensure 10 million covid-19 tests a day, show it’s likely that new testing technology would need to be developed, validated, procured, and made operational within months to meet the early 2021 deadline.
Jon Deeks, professor of biostatistics at the University of Birmingham and leader of the Cochrane Collaboration’s covid-19 test evaluation activities, has described the plan as a “nice dream.”
He told The BMJ, “This is not the way we should be tackling something when people are dying right now: thinking about things we have not got. We should be thinking about the things we have got and we know work. Backing a horse that hasn’t yet been born is a really bad strategy.”
https://www.bmj.com/content/370/bmj.m3585
(Published 23 October 2020)
The UK government has abandoned plans to spend £100bn on a massive expansion of its national testing programme, legal documents have shown.
A letter from government lawyers also reveals that the ambitious Operation Moonshot programme, first revealed in leaked documents seen by The BMJ last month, has now been quietly subsumed by the national test and trace programme.
https://www.bmj.com/content/371/bmj.m4112
Apparently so, but it is a soooooo slowwwww PCR.
https://www.google.co.uk/amp/s/www.businessinsider.com/coronavirus-variant-france-can-evade-tests-2021-3%3famp
On the 1st of March the RNS said within a period of 4 weeks they will be able to ‘hopefully’ confirm a lower limit of detection.
It is price sensitive information as the levels of detection are crucial. They have a duty to shareholders and the market to release price sensitive information ASAP.
End of April is a ‘further’ update for the results of the prospective clinical trial.
There are 6 trading days left until that 4 week period expires.
I think we need something more robust..
Can mouthwash kill the coronavirus?
Technically, yes—some types of mouthwash with certain active ingredients have been shown to inactivate SARS-CoV-2 in vitro, or outside of its normal biological context (aka, in a laboratory setting), albeit one that mimicked the conditions of the naso/oropharynx, or back of the throat.
https://www.google.co.uk/amp/s/www.health.com/condition/infectious-diseases/coronavirus/does-mouthwash-kill-covid-19%3famp=true
Alcohol has antimicrobial properties. This means that, at the right concentration (strength), it can destroy germs such as bacteria and viruses. But, as with most things, its effectiveness depends on various factors.
https://www.healthline.com/health/does-alcohol-kill-germs
Anyone for a Vodka?